Sulakhe P V, McNamara D B, Dhalla N S
Recent Adv Stud Cardiac Struct Metab. 1976;9:279-302.
The Km value for the dog heart (Na+-K+)-ATPase was 0.31 mM (MgATP), whereas the values for the concentrations of K+ and Na+ varied from 1.2 to 2.7 mM and 12 to 20 mM for half-maximal activation, respectively. The concentrations of ouabain and calcium for 50 percent inhibition of (Na+-K+)-ATPase activity varied from 2.4 to 3.2 muM and 0.5 to 1.2 mM, respectively, the inhibitory effects of these agents were pH dependent. This preparation bound about 50 nmoles of 1-anilino-8-napthaline sulfonate (ANS)/mg of protein and exhibited fluorescence attributable to the ANS-enzyme complex. Cations such as Na+,K+,Ca++, and Mg++ increased ANS-enzyme fluorescence intensity and the number of ANS binding sites but decreased the apparent ANS binding constant. The enzyme activity, ANS binding, and ANS-enzyme fluorescence were decreased by phospholipase A, phospholipase C, and trypsin treatments. Although ouabain inhibited enzyme activity and ANS-enzyme fluorescence markedly, it caused only a slight depression in ANS binding. These results extend support for the allosteric nature of the cardiac (Na+-K+)-ATPase and provide evidence for conformational changes during its activation by Na+ and K+.
犬心脏(Na + -K +)-ATP酶的米氏常数(Km)为0.31 mM(MgATP),而对于K +和Na +浓度,在半最大激活时分别为1.2至2.7 mM和12至20 mM。哇巴因和钙对(Na + -K +)-ATP酶活性50%抑制时的浓度分别为2.4至3.2 μM和0.5至1.2 mM,这些药物的抑制作用依赖于pH值。该制剂每毫克蛋白质结合约50纳摩尔的1-苯胺基-8-萘磺酸盐(ANS),并表现出归因于ANS-酶复合物的荧光。诸如Na +、K +、Ca ++和Mg ++等阳离子增加了ANS-酶荧光强度和ANS结合位点数量,但降低了表观ANS结合常数。磷脂酶A、磷脂酶C和胰蛋白酶处理降低了酶活性、ANS结合和ANS-酶荧光。尽管哇巴因显著抑制酶活性和ANS-酶荧光,但它仅使ANS结合略有降低。这些结果进一步支持了心脏(Na + -K +)-ATP酶的别构性质,并为其被Na +和K +激活过程中的构象变化提供了证据。